Introduction
The GORE EXCLUDER Iliac Branch Endoprosthesis (IBE; W. L. Gore and Associates, Flagstaff, AZ, USA) was approved by the Japanese Food and Drug Administration in 2017 for endovascular treatment of common iliac aneurysms as an adjunct to endovascular aneurysm repair (EVAR). However, due to ethnic differences in iliac length among the Japanese population, 1, 2) the IBE s applicability is anatomically limited by the shorter aorto-iliac length (AOL). We present a unique application for the IBE device with a contra-lateral side of the limb wound around the ipsilateral limb. In accordance with our hospital s institutional review board guidelines, written informed consent was obtained from the patient for this procedure and publication.
Case Report
An 85-year-old male (150 cm) presented to our emergency department with throbbing left abdominal pain and occultly increased blood pressure (190 mmHg). A computed tomography scan demonstrated an unchanged, pre-existing, fusiform type of 43-mm abdominal aortic aneurysm (AAA), and a saccular type of 35-mm left common iliac arterial aneurysm (LCIAA), which had not been detected in the previous computerized tomography (CT) scan about a year ago. The pain severity could be reduced by lowering the pressure. His medical history included abdominal incisional hernia after cholecystectomy, hypertension, hyperlipidemia, chronic obstructive pulmonary disease, and left hemisphere brain infarction. After the brain infarction, the patient had claudication, using the left leg as a dominant one. The patient was referred to our department for an endovascular solution of the LCIAA.
Our goal was to try and preserve the patient s pelvic circulation. The right hypogastric artery (HA) was highly calcified and severely stenosed at the proximal orifice. Therefore, the IBE device s anatomical suitability for his left iliac artery was investigated using imaging analysis software (Osirix MD, Pixmeo, Bernex, Switzerland). The centerline length, from the lowest renal arterial level of aorta to the left HA opening, was 146-mm ( Fig. 1) . The length was deemed too short because, with a 23-mm proximal diameter, the recommended minimum length is 165-mm for the combined use of the trunk-ipsilateral device (TID). To deal with the 19-mm shortage of the Spiral Deployment of Connection Device for IBE AOL, crossed limb (CXL) fashion of contra-lateral limb alignment was then considered, but increasing the device implantation line (DIL) length seemed insufficient. Then, we came up with an alternative implanting plan of a connection stent-graft (CSG), with a DIL wound half-circumferentially around the ipsilateral limb (IPL) of the TID. The increased DIL by this modified deployment is not less than a half-circumferential length (HCL) of the IPL. Since the IPL diameter is 14.5-mm, the HCL is calculated as: π°°≈ = × × HCL 14.5 180 /360 23-mm
Consequently, the assumption was made that CSG deployment using this technique would correct the DIL shortage. A description of our technique follows. The IBE and iliac branch component devices (IBC) were deployed as usual. TID was deployed, with the contra-lateral limb initially located in the direction of 3-p.m. The contra-lateral gate was wire-cannulated from the left femoral access ( Fig. 2A) . It seemed unlikely that cross-leg positioning of the contra-lateral gate could have gained sufficient length, even for using the 10 cm connection bellbottom stentgraft. Using the C3 function, the TID was rotated 360° counterclockwise, confirming the winding DIL formation along with increased length (Fig. 2B) . The measurement of the length of shortest (i.e., small-curvature sided) device path was estimated to be 100-mm. Consequently, a device measuring 125-mm long, with a distal diameter of 27-mm leg, was selected as a CSG.
The IPL was deployed with the distal end floating inside the AAA. The CSG was deployed slowly, adjusting its distal landing point by changing the axis of the winding path (i.e., IPL device path). After the device components were connected successfully, the ipsilateral side of the graft was extended using a 95-mm length with a distal diameter of 20-mm leg as the extender. No endoleak was detected in the completion angiography. Post-operative CT demonstrated that the contra-lateral connection stentgraft was beautifully wound around the ipsilateral limb with a Pretzel -look (Fig. 3) . The post-operative course was uneventful. There was no limb occlusion or proximal migration of the device for 12 months. 
Discussion
The HAs and their branches form an ample network of anastomotic connections with arteries, such as the inferior mesenteric artery, lumbar arteries, external iliac arteries, and arteria profunda femoris. Bilateral HA flowinterruption during the EVAR procedure decreases pelvic blood flow. One study indicated that the severity of pelvic organ ischemia would be mitigated, to a level achieved by activating or establishing collateral circulation, and that maintaining at least one side of HA increased the recovery level. 3) Because advancement of collateral networks differs in each individual, depending on the patency of the preoperative inferior mesenteric artery and the HAs, with and without peripheral artery occlusive disease, new onset of buttock claudication could range from 10-50% after EVAR with the HA flow cessation. [4] [5] [6] [7] [8] Decreased pelvic circulation seemed to last more than half a year. 7) In the present case, it seemed highly likely that the left HA embolization would cause severe buttock claudication of the left side and increase frailty with one severely occluded HA preserved in the right side.
To preserve pelvic circulation, iliac branch devices, including the IBE and Iliac Branch Device (IBD, Cook, Bloomington, IN, USA), have been developed. The AOL limits these devices applicability. One study reported that the average AOL of older Japanese AAA patients was less than 150-mm. 1) Another study reported that 24% of Japanese patients with aorto-iliac aneurysms were excluded because the AOL was too short for the device size. 2) Taking other anatomical factors into account, only 40% of patients could be treated by these devices. 2) In the case of insufficient common iliac length, even if the AOL was sufficient, the IBE can be used with the proximal end of the device located in the AAA, and the internal iliac component could be deployed using brachial or axillar access. 9) However, with insufficient AOL, there seemed to be no alternative option but to modify the DIL in some way. If the AOL is minimally short, curving the CSG deployment line (usually accomplished by slow-deployment and pushing the device) might adjust the device-path and length. If an excessive level of the curve modification strength is applied during the deployment, it may cause proximal migration of all stent-graft components. Although the method in this report is also an outside-the-IFU (instruction for use) use of device, it might reduce the amplitude of longitudinal force applied to the devices compared to the aforementioned form of deployment.
The CXL and customary bifurcated stent-grafts reportedly present similar hemodynamic and clinical performances. 10) Since the implantation line s wound portion tracked smoothly, this form of limb deployment would not make a significant difference in IBE clinical results.
Similar to the CXL form of deployment, it may help avoid an abrupt curve of the DIL in case of a widespread angle of the common iliac arteries. 10) However, caution should be exercised because we may not be able to predict the accurate length of the CSG preoperatively. Therefore, intraoperative measurement is necessary for this technique. Limb deployment can be conducted without using the C3 repositioning function, but it may be technically challenging. TID rotation should be performed with caution because the device-trunk s friction may injure the endoluminal surface of the proximal neck. In addition, the rotation should be limited to a minimum degree so the main device would not be squeezed and occluded. Caution also should be taken about the existence of an adequate vessel volume for the winding leg to be deployed. Since this technique would be used in case of a short deployment-length, 360° degree of rotation seemed to be the maximum. Long-term follow-up using imaging technologies is necessary.
In conclusion, use of an IBE device is limited by the AOL. This Pretzel-form of device alignment could increase the device implantation line for the IBE side, allowing more patients to be treated and therefore preserving pelvic circulation.
